Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 03 - 03 tags : Biotech-bay save search
Corvus Pharmaceuticals to Provide Business Update and Report Fourth Quarter and Full Year 2021 Financial Results on March 10, 2022
Published: 2022-03-03 (Crawled : 22:00) - biospace.com/
CRVS | $1.53 6.25% 5.88% 140K
|
Health Technology
|
| O: 2.38%
H: 0.0%
C: -5.81%
als financial results report results
Satsuma Pharmaceuticals Announces Abstracts Accepted for Presentation at the American Academy of Neurology 2022 Annual Meeting
Published: 2022-03-03 (Crawled : 22:00) - biospace.com/
STSA | $1.1 -0.9% -0.91% 0
|
Health Technology
|
| O: 4.11%
H: 0.0%
C: -2.63%
america als ces presentation
Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights
Published: 2022-03-03 (Crawled : 22:00) - biospace.com/
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: -5.26%
H: 0.0%
C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -2.63%
H: 0.9%
C: -0.3%
als financial results report results
Annexon Biosciences to Present Preclinical Data Supporting Complement Inhibitor Programs for the Treatment of Guillain-Barré Syndrome and Huntington’s Disease at AAN 2022
Published: 2022-03-03 (Crawled : 22:00) - biospace.com/
ANNX | $4.46 -1.87% -1.91% 800K
|
Health Technology
|
| O: 1.3%
H: 0.0%
C: -6.21%
huntington treatment program disease preclinical bioscience syndros pre-clinical huntington’s disease
Rain Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Progress
Published: 2022-03-03 (Crawled : 22:00) - biospace.com/
RAIN | $1.21 0.0% 3.7M
|
Manufacturing
|
| O: 2.9%
H: 0.0%
C: -10.76%
financial results therapeutics report results
Helsinn Group and BridgeBio Pharma Announce Update to Strategic Collaboration to Develop, Manufacture and Commercialize Infigratinib in Oncology Indications in the U.S.
Published: 2022-03-03 (Crawled : 19:00) - biospace.com/
BBIO | $25.43 1.44% 1.42% 1.1M
|
Health Technology
|
| O: -1.09%
H: 3.3%
C: -3.43%
collaboration group
Better Therapeutics Sponsors Educational Symposium on the Use of Software as a Next-Generation Treatment for Cardiometabolic Diseases
Published: 2022-03-03 (Crawled : 17:00) - biospace.com/
BTTX | $0.0061 -65.02% 300K
|
|
| O: 0.0%
H: 3.46%
C: -3.08%
treatment symposium metabolic cardio therapeutics disease education software pons
Roche Plans Ambitious Phase III Alzheimer's Study
Published: 2022-03-03 (Crawled : 16:00) - biospace.com/
MOR | News | $18.04 0.45% 0.44% 180K
|
Health Technology
|
| O: -2.24%
H: 0.31%
C: -5.34%
alzheimer alzheimer’s alzheimer's
Graphite Bio Announces Participation in Upcoming Cowen 42nd Annual Health Care Conference
Published: 2022-03-03 (Crawled : 14:00) - biospace.com/
GRPH 4 | $3.27 1.84% 490K
|
Professional, Scientific, and T...
|
| O: -1.63%
H: 1.71%
C: -5.08%
health conference
Innoviva, Inc. Prices Upsized Offering of $225 Million of 2.125% Convertible Senior Notes
Published: 2022-03-03 (Crawled : 13:00) - biospace.com/
INVA | $15.16 1.54% 1.52% 1.5M
|
Health Technology
|
| O: 6.62%
H: 0.16%
C: -7.35%
offering ces
Gainers vs Losers
| 79% | 21% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 870K
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.